Hypobaric hypoxic cerebral insults: The neurological consequences of going higher

NeuroRehabilitation

Volumn 26, Issue 1, 2010, Pages 73-84

  Maa, Edward H ^a  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

Author keywords

Acute mountain sickness; High altitude; High altitude cerebral edema; High altitude headache; Hypobaric hypoxia; Seizure

Indexed keywords

ACETAZOLAMIDE; ALPHA TOCOPHEROL; ANALGESIC AGENT; ASCORBIC ACID; CRATAEGUS EXTRACT; DEXAMETHASONE; GINKGO BILOBA EXTRACT; GLUTAMINE; PARACETAMOL; SILYBUM MARIANUM EXTRACT; THIOCTIC ACID;

ALTITUDE DISEASE; BRAIN EDEMA; BRAIN HYPOXIA; BRAIN INJURY; CLINICAL FEATURE; COGNITIVE DEFECT; CRANIAL NERVE PARALYSIS; DRUG DOSE COMPARISON; HEADACHE; HUMAN; HYPOBARISM; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; OXYGEN THERAPY; PATHOPHYSIOLOGY; RETINA HEMORRHAGE; REVIEW; SEIZURE; SLEEP DISORDER; TRANSIENT ISCHEMIC ATTACK; VEIN THROMBOSIS; VISUAL DISORDER;

ALTITUDE SICKNESS; BRAIN EDEMA; CEREBRAL CORTEX; COGNITION DISORDERS; HUMANS; HYPOXIA, BRAIN; MOVEMENT DISORDERS; NERVOUS SYSTEM DISEASES; SLEEP DISORDERS; VISION DISORDERS;

EID: 76649117430     PISSN: 10538135     EISSN: None     Source Type: Journal    
DOI: 10.3233/NRE-2010-0537     Document Type: Review

References (77)

1. A.C. Anand, V.K. Sashindran and L. Mohan, Gastrointestinal problems at high altitude, Trop Gastroenterol 27(4) (2006), 147-153.
2. J.D. Anholm, A.C. Powles, R. Downey, 3rd, C.S. Houston, J.R. Sutton, M.H. Bonnet et al., Operation Everest II: arterial oxygen saturation and sleep at extreme simulated altitude, Am Rev Respir Dis 145(4 Pt 1) (Apr 1992), 817-826.
3. D.M. Bailey, R. Roukens, M. Knauth et al., Free radicalmediated damage to barrier function is not associated with altered brain morphology in high-altitude headache, J Cereb Blood Flow Metab 26(1) (2006), 99-111.
4. D.M. Bailey, S. Taudorf, R.M. Berg et al., Transcerebral exchange kinetics of nitrite and calcitonin gene-related peptide in acute mountain sickness: evidence against trigeminovascular activation? Stroke 40(6) (2009), 2205-2208.
5. B. Basnyat, Seizure and hemiparesis at high altitude outside the setting of acute mountain sickness, Wilderness Environ Med 8 (1997), 221-222.
6. B. Basnyat, Fatal grand mal seizure in a Dutchtrekker, J Travel Med 5 (1998), 221-222.
7. B. Basnyat, Seizures at high altitude in a patienton antiseizure medications, Wilderness Environ Med 12 (2001), 153-154.
8. B. Basnyat, J.H. Gertsch, P.S. Holck et al., Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial, High Alt Med Biol 7 (2006), 17-27.
9. B. Basnyat. T. Wu and J.H. Gertsch, Neurological conditions at altitude that fall outside the usual definition of altitude sickness, High Alt Med Biol 5 (2004), 171-179.
10. R.W. Baumgartner, P. Bartsch, M. Maggiorini et al., Enhanced cerebral blood flow in acute mountain sickness, Aviat Space Environ Med 65 (1994), 726-729.
11. R.W. Baumgartner, I. Spyridopoulos, P. Bartsch et al., Acute mountain sickness is not related to cerebral blood flow: a decompression chamber study, J Appl Physiol 86 (1999), 1578-1582.
12. C.M. Beall, D. Laskowski, K.P. Strohl et al., Pulmonary nitric oxide in mountain dwellers, Nature 414 (2001), 411-412.
13. B. Bolmont, C. Bouquet and F. Thullier, Relationships of personality traits with performance in reaction time, psychomotor ability, and mental efficiency during a 31-day simulated climb of Mount Everest in a hypobaric chamber, Percept Mot Skills 92 (2001), 1022-1030.
14. M.M. Bosch, T.M. Merz, D. Barthelmes et al., New insights into ocular blood flow at very high altitudes, J Appl Physiol 106(2) (2009), 454-460.
15. P. Brugger, M. Regard, T. Landis and O. Oelz, Hallucinatory experiences in extreme-altitude climbers, Neuropsychiatry Neuropsychol Behav Neurol 12(1) (1999), 67-71.
16. K.R. Burgess, J. Cooper, A. Rice et al., Effect of simulated altitude during sleep on moderate-severity OSA, Respirology 11 (2006), 62-69.
17. K.R. Burgess, P. Johnson, N. Edwards and J. Cooper, Acute mountain sickness is associated with sleep desaturation at high altitude, Respirlogy 9 (2004), 485-492.
18. M. Burtscher, High altitude headache: epidemiology, pathophysiology, therapy and prophylaxis, Wien Klin Wochenschr 111(20) (1999), 830-836.
19. C. Dehnert, J. Weymann, H.E. Montgomery et al., No association between high altitude tolerance and the ACE I/D gene polymorphism, Med Sci Sports Exerc 34 (2002), 1928-1933.
20. J. Dickinson, Acute mountain sickness: a dissertation based on 11 years experience in the Nepal Himalaya. Oxford University, Oxford (1981), 98.
21. Y. Droma, M. Hanoaka, B. Basnyat et al., Adaptation to high altitude in Sherpas: association with the insertion/deletion polymorphism in the angiotensin converting enzyme gene, Wilderness Environ Med 19 (2002), 22-29.
22. S.C. Erzurum, S. Ghosh, A.J. Janocha et al., Higher blood flow and circulating NO products offset high altitude hypoxia among Tibetans, Proc Natl Acad Sci USA 104 (2007), 17593-17598.
23. P.H. Hackett, The cerebral etiology of high altitude cerebral edema and acute mountain sickness, Wilderness Environ Med 10 (1999), 97-109.
24. P.H. Hackett, High-altitude illness, N Engl J Med 345(2) (2001), 107-114.
25. P.H. Hackett, D. Rennie and H.D. Levine, The incidence, importance and prophylaxis of acute mountain sickness, Lancet 2 (1976), 1149-1155.
26. P.H. Hackett and R.C. Roach, High altitude cerebral edema, High Alt Med Biol 5 (2004), 136-146.
27. P.H. Hackett, P.R. Yarnell, R. Hill et al., High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology, JAMA 280 (1998), 1920-1925.
28. N.S. Harris and S.W. Nelson, Altitude Illness - Cerebral Syndromes. In EMedicine [online]. Available at: http://emedicine. medscape.com/article/768478- overview Accessed January 22, 2009.
29. G. Hartig and P. Hackett, Cerebral spinal fluid pressure and cerebral blood velocity in acute mountain sickness, in: Hypoxia and Mountain Medicine, C. Houston, ed., Oxford: Pergamon Press, 1992, pp. 260-265.
30. P.W. Hochachka and C. Monge, Evolution of human hypoxia intolerance physiology, Adv Exp Med Biol 475 (2000), 25-43.
31. B. Honigman, M.K. Theis, J. Koziol-McLain et al., Acute mountain sickness in a general tourist population at moderate altitudes, Ann Intern Med 118(8) (1993), 587-592.
32. C.H. Imray, N.J. Barnett, S. Walsh et al., Near-infrared spectroscopy in the assessment of cerebral oxygenation at high altitude, Wilderness Environ Med 9 (1998), 198-203.
33. International Headache Society. IHS classification ICHDII: High altitude headache. http://ihsclassification.org/en/02 klassifikation/03 teil2/10.01.01 homoeostasis.html. Accessed March 2, 2009.
34. S. Jafarian, F. Gorouhi, A. Taghva and J. Lotfi, High altitude sleep disturbance: results of the Groningn Sleep Quality Questionnaire survey, Sleep Med 9 (2008), 446-449.
35. G.F.A. Jansen, A. Krins, B. Basnyat et al., Cerebral autoregulation in subjects adapted and not adapted to high altitude, Stroke 31 (2000), 2314-2318.
36. J.B. Jensen, A.D. Wright, N.A. Lassen et al., Cerebral blood flow in acute mountain sickness, J Appl Physiol 69 (1990), 430-433.
37. D. Jimenez, High Altitude Intermittent Chronic Exposure: Andean Miners, in: Hypoxia and the Brain, J.R. Sutton et al., Queen City Printers, Burlington, VT, 1995, pp. 284-291.
38. K. Kallenberg, D.M. Bailey, S. Christ et al., Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness, J Cerb Blood Flow Metab 27 (2007), 1064-1071.
39. K. Kallenberg, C. Dehnert, A. Dorfler et al., Microhemorrhages in nonfatal high altitude cerebral edema, J Cereb Blood Flow Metab 28 (2008), 1635-1642.
40. J.F. Kasic, H.M. Smith and R.I. Gamow, A self-contained life support system designed for use with a portable hyperbaric chamber, Biomed Sci Instrum 25 (1989), 79-81.
41. B. Kayser, M. Narici, T. Binzoni et al., Fatigue and exhaustion in chronic hypobaric hypoxia: influence of exercising muscle mass, J Appl Physiol 76 (1994), 634-640.
42. A.F. Kramer, J.T. Coyne and D.L. Strayer, Cognitive function at high altitude, Hum Factors 35 (1993), 329-344.
43. N.P. Lawless, T.A. Dillard, K.G. Torrington et al., Improvement in hypoxemia at 4600 meters of simulated altitude with carbohydrate ingestion, Aviat Space Environ Med 70 (1999), 874-878.
44. Longwoods International, Colorado Travel Year 2005: Visitor Profile, Colorado Tourism Office, 2006.
45. K. Maakestad, G. Leadbetter, S. Olson and P. Hackett, Ginko biloba reduces incidence and severity of acute mountain sickness. (Abstract) Proceedings Wilderness Medical Society Summer Conference, Park City, Utah. August 9-12, 2000.
46. J.K. Mansoor, B.M. Morrissey, W.F. Walby et al., L-Arginine Supplementation Enhances Exhaled NO, Breath Condensate VEGF, and Headache at 4342 m, High Alt Med Biol 6 (2005), 289-300.
47. R.A. McFarland, Psychophysiological Implications of Life at Altitude and Including the Role of Oxygen in the Process of Aging, in: Physiological Adaptations, M.K. Yousef et al., Academic Press, New York, 1972, pp. 157-182.
48. Mosso. Life of Man in the High Alps, T. Fisher Unwin: London, 1898.
49. P. Napier and J.B.West, High altitude medical and operations problems and solutions for the Millimeter Array, in: Society of Photo-Optical Instrumentation Engineers, 1998.
50. K. Nielsen, [Personal communication]. June 2008.
51. S.M. Otis, M.E. Rossman, P.A. Schneider et al., Relationship of cerebral blood flow regulation to actue mountain sickness, J Ultrasound Med 8 (1989), 143-148.
52. R.L. Pearson, A. Thompson, J. Murray and K Bailey, Altitude Sickness. In: First Consult [online]. Available at www.mdconsult.com. Accessed January 22, 2009.
53. C. Rajput, E. Arif, A. Vibhuti et al., Predominance of interaction among wild type alleles of CYP11B2 in Himalayan natives associates with high altitude adaptation, Biochem Biophys Res Commun 348 (2006), 735-740.
54. J.W. Severinghaus, H. Chiodi, E.I. Eger II et al., Cerebral blood flow in man at high altitude. Role of cerebrospinal fluid pH in normalization of flow in chronic hypocapnia, Circ Res 19 (1966), 274-282.
55. E.H. Shackleton, F. Hurley and F. Fleming, South: The Endurance Expedition, Penguin Classics (1914), 204.
56. M.F. Shackleton, C.M. Tondora, S. Whiting and M. Whitney, The effect of homeopathic coca on high altitude mountain sickness: Mt. Everest Base Camp, Complementary Health Pratice Review 6(1) (2000), 45-55.
57. L.A. Steiner and P.J. Andrews, Monitoring the injured brain: ICP and CBF, British Journal of Anaesthesia 97(1) (2006), 26-38.
58. T. Stobdan, J. Karar and M.A. Pasha, High altitude adaptiation: genetic perspectives, High Alt Med Biol 9 (2008), 140-147.
59. A.W. Subudhi, K.A. Jacobs, T.A. Hagobian et al., Changes in ventilatory threshold at high altitude: effect of antioxidants, Med Sci Sports Exerc 38 (2006), 1425-1431.
60. A.W. Subudhi, M.C. Lorenz, C.S. Fulco and R.C. Roach, Cerebrovascular responses to incremental exercise during hypobaric hypoxia: effect of oxygenation on maximal performance, Am J Physiol Heart Circ Physiol 294 (2008), H164-H171.
61. P. Suedfeld and J. Geiger, The sensed presence as a coping resource in extreme environments, in: Miracles God, (Vol 3), J.H. Ellens, ed., Science, and Psychology in the Paranormal, Praeger, 2008.
62. A.I. Sutherland, D.S. Morris, C.G. Owen et al., Optic nerve sheath diameter, intracranial pressure and acute mountain sickness on Mount Everest: a longitudinal cohort study, Br J Sports Med 42 (2008), 183-188.
63. J.R. Sutton, G. Coates and C.S. Houston, eds, The Lake Louise Consensus on the Definition and Quantification of Altitude Illness, in: Hypoxia and Mountain Medicine, Queen City Printers, Burlington, Vermont, 1992.
64. K. Suzuki, T. Kiszaki, Y. Hitomi et al., Genetic variation in hypoxia inducible factor 1 alpha and its possible association with high altitude adaptation in Sherpas, Med Hyptheses 61 (2003), 385-389.
65. A. Van Osta, J.J. Moraine and C. Melot et al., Effects of high altitude exposure on cerebral hemodynamics in normal subjects, Stroke 36 (2005), 557-560.
66. J. Vuyk, J. Van Den Bos, K. Terhell et al., Acetazolamide improves cerebral oxygenation during exercise at high altitude, High Alt Med Biol 7 (2006), 290-301.
67. N.J.Wesenten, J. Crowley, T. Balkin et al., Effect of simulated high altitude exposure on long-latency event related brain potentials and performance, Aviat Space Environ Med 64 (1993), 30-36.
68. J.B. West, Human physiology at extreme altitudes on Mount Everest, Science 223 (1984), 784-788.
69. J.B. West, Paralysis and blindness during a balloon ascent to high altitude, High Altitude Medicine & Biology 5(4) (2004), 453-456.
70. M.H.Wilson, M. Edsel, C. Imray, A. Wright et al., Changes in pupil dynamics at high altitude-an observational study using a handheld pupillometer, High alt Med Biol 9 (2008), 319-325.
71. M.H.Wilson and J. Milledge, Direct measurement of intracranial pressure at high altitude and correlation of ventricular size with acute mountain sickness: Brian Cummins' results from the 1985 Kishtwar expedition, Neurosurgery 63 (2008), 970-974.
72. M.H.Wilson, S. Newman and C.H. Imray, The cerebral effects of ascent to high altitudes, Lancet Neurol 8 (2009), 175-191.
73. D.r. Woods and H.E. Montgomery, Angiotensin converting enzyme and genetics at high altitude, High Alt Med Biol 2 (2001), 201-210.
74. A.D. Wright, C.H. Imray, M.S. Morrissey et al., Intracranial pressure at high altitude and acute mountain sickness, Clin Sci 89 (1995), 201-204.
75. T.Y. Wu, S.Q. Ding, J.L. Liu et al., Who should not go high: chronic disease and work at altitude during construction of the Qinghai-Tibet railroad, High Alt Med Biol 8 (2007), 88-107.
76. P.R. Yarnell, J. Heit and P.H. Hackett, High-altitude cerebral edema (HACE): the Denver/Front Range experience, Semin Neurol 20(2) (2000), 209-217.
77. X.D. Zhou, Transient ischemic attack in young people at high altitude, Qinghai Med J 14(2) (1984), 44-45.